SECOND OPINION: BIG PHARMA SQUARELY TO BLAME FOR RISING MEDICARE PREMIUMS

Drug Makers Cry ‘False Narrative’ Over Latest Repot Highlighting Toll of the Industry’s Egregious Pricing Practices Last week, the Centers for Medicare & Medicaid Services (CMS) released a

11-12-2019 Read More

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices Top Brand Name Drug Makers Best Earnings Forecasts While Evading Accountability And that’s a wrap! Three weeks of earnings

11-7-2019 Read More

AMERICANS AGREE: CONGRESS MUST ACT TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES

Solutions to Reform Medicare Part D, Increase Competition and Boost Transparency Have Broad Bipartisan Support, Should Be Swiftly Passed THE CRISIS OF RISING PRESCRIPTION DRUG PRICES The

11-4-2019 Read More

Big Pharma Earnings Watch: Abbvie

Brand Name Drug Giant Completes Sweep of Big Pharma Companies Who Beat Expectations After Hiking Prices Earnings reports for the third quarter of the year provide the latest evidence that Big Pharma

11-1-2019 Read More

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB AND SANOFI

Good Times Rolling for Brand Name Drug Makers, Two More Top Earnings Forecasts After Increasing Prices Two more brand name giants – Bristol-Myers Squibb and Sanofi – topped earnings expectations

10-31-2019 Read More

Big Pharma Earnings Watch: Glaxosmithkline and Amgen

Big Pharma’s Earnings Keep Rising Off of Price Hikes To no one’s surprise, two more brand name drug manufacturers, GlaxoSmithKline (GSK) and Amgen both topped earnings expectations for the third

10-30-2019 Read More

Big Pharma Watch: Merck and Pfizer

Two More Big Pharma Giants Beat Q3 Forecasts After Hiking Prices On Cancer And Arthritis Drugs Kicking off the final week of Q3 earnings reports, two more brand name giants – Merck and Pfizer –

10-29-2019 Read More

Big Pharma Earnings Watch: Eli Lilly

Pharmaceutical Giant Beats Q3 Profit Forecasts After Hiking Prices on Drugs Used to Treat Diabetes and Cancer Yesterday, Eli Lilly joined fellow Big Pharma giants Johnson & Johnson, Roche and

10-24-2019 Read More

Big Pharma Earnings Watch: Astrazeneca

Another Brand Name Drug Maker Beats Expectations After Raising Prices Rounding out this week’s reporting on third quarter earnings, Big Pharma giant AstraZeneca joined four other brand name giants

10-24-2019 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.